Ana Luisa Soares de Miranda

Dr. Ana Luisa Soares de Miranda

Centro Universitário de Belo Horizonte, Belo Horizonte, Minas Gerais, Brazil
+1
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Journal of Equine Veterinary Science
Verified
Journal Article
Closed access
AMAna Luisa Soares de Miranda
Ana Luisa Soares de Miranda
BSBenito Soto-Blanco
Benito Soto-Blanco
PLPaula R. Lopes
Paula R. Lopes
RVRaphael M. Victor
Raphael M. Victor
MPMaristela S. Palhares
Maristela S. Palhares

26 September 2023 in Toxins
Verified
Journal Article
Open access
PDF file
AMAna Luisa Soares de Miranda
Ana Luisa Soares de Miranda
BABruno Cesar Antunes
Bruno Cesar Antunes
JMJoão Carlos Minozzo
João Carlos Minozzo
SLSabrina de Almeida Lima
Sabrina de Almeida Lima
ABAna Flávia Machado Botelho
Ana Flávia Machado Botelho
BSBenito Soto-Blanco
Benito Soto-Blanco
Antivenom production against Loxosceles venom relies on horses being immunized and bled for plasma harvest. One horse can partake in several cycles of antivenom production, which will require years of constant venom and adjuvant inoculation and bleeding. The actual impact on the health of horses that participate in several antivenom-producing cycles is unknown. Therefore, this study aimed to evaluate the general health status of horses that underwent at least six cycles of loxoscelic antivenom production. Seven crossbred horses that had partaken in six to eight complete antivenom-producing cycles were used and established as the immunized group (IG). Under the same handling and general management, eleven horses were established as the control group (CG). The horses were evaluated regarding their general clinical status and had their blood sampled, and an ECG recorded. The IG presented lower RBC and PCV, despite keeping values within inferior limits for the species. Renal function was not impaired, and liver-related enzymes were higher than those in the CG, probably due to liver exertion from immunoglobulin synthesis. ECG showed some abnormalities in the IG, such as atrioventricular block and a wandering atrial pacemaker, corroborated by an increase in CK-MB. The cardiovascular abnormalities were mainly found in the horses that participated in several antivenom-producing cycles. The overall results indicate that these horses had some impairment of their general health status. Once available, some alternative, less toxic antigens should replace the venom for immunization of horses used for antivenom production.

13 May 2022 in Toxins
Verified
Journal Article
Open access
PDF file
AMAna Luisa Soares de Miranda
Ana Luisa Soares de Miranda
BABruno Cesar Antunes
Bruno Cesar Antunes
JMJoão Carlos Minozzo
João Carlos Minozzo
SLSabrina de Almeida Lima
Sabrina de Almeida Lima
ABAna Flávia Machado Botelho
Ana Flávia Machado Botelho
BSBenito Soto-Blanco
Benito Soto-Blanco
Bites of brown spiders (Loxosceles spp.) are responsible for dermonecrotic lesions and potentially systemic envenoming that can lead to death. The only effective therapy is the use of the antivenom, usually produced in horses. However, little is known about the consequences of the systematic use of the Loxosceles venom and adjuvants and of the bleedings on antivenom-producing horses. Thus, the aim of this study was to evaluate the clinical changes in horses in their first immunization protocol for Loxosceles antivenom production. Eleven healthy horses, never immunized, were evaluated in three different periods: T0 (before immunization); T1 (after their first venom immunization); and T2 (after their first bleeding). Horses were clinically evaluated, sampled for blood, and underwent electrocardiographic (ECG) recordings. Several suppurated subcutaneous abscesses occurred due to the use of Freund’s adjuvants and thrombophlebitis due to systematic venipunctures for the bleeding procedures. ECG showed arrhythmias in few horses in T2, such as an increase in T and R waves. In summary, the immunization protocol impacted on horses’ health, especially after bleeding for antivenom procurement.

1 February 2022 in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
Verified
Journal Article
Open access
PFPRISCILA FANTINI
PRISCILA FANTINI
RJR. Jimenez-Aristizabal
R. Jimenez-Aristizabal
AIA. Iborra
A. Iborra
AMAna Luisa Soares de Miranda
Ana Luisa Soares de Miranda
RMR.P.A. Maranhão
R.P.A. Maranhão
MPMarta Prades
Marta Prades
Platelet-rich plasma (PRP) has been proposed as an agent to accelerate the healing process and stimulate the regenerative capacity of tissues due to its abundance of growth factors. A large variety of kits and protocols are available to obtain PRP by different cell-separation systems. However, the lack of standardization may lead to inconsistent results. The aim of this study was to characterize cellular composition, platelet parameters using the ADVIA 120 flow cytometer, and TGF-β1 concentration from the PRP product obtained through a closed system, using simple centrifugation. Six clinically healthy horses were used in this study. The protocol in the closed system resulted in approximately 1.6-fold higher platelet and approximately 2.0-fold lower white blood cell concentrations in comparison with whole blood values. The evaluated system was efficient in concentrating platelets and in retrieving a small number of leukocytes, using a protocol of single centrifugation at low speed.

20 May 2025 in Journal of Equine Veterinary Science
Verified
Journal Article
Closed access
FPF.M. Pastor
F.M. Pastor
AMAna Luisa Soares de Miranda
Ana Luisa Soares de Miranda
NMN.C.C. Monteiro
N.C.C. Monteiro
TCT.S. Carvalho
T.S. Carvalho
CDC.A. Diamantino
C.A. Diamantino
RSRogeria Serakides
Rogeria Serakides

1 January 2025 in Ciência Rural
Verified
Journal Article
Open access
PDF file
NCNelcimara Mirley de Souza Correia
Nelcimara Mirley de Souza Correia
WFWagner Luís Fernandes
Wagner Luís Fernandes
MLMary Ane Gonçalves Lana
Mary Ane Gonçalves Lana
IMIsadora David Tavares de Moraes
Isadora David Tavares de Moraes
JNJulia Paiva Nunes
Julia Paiva Nunes
ABAna Flávia Machado Botelho
Ana Flávia Machado Botelho
Ionophores are polyether antibiotics used in animal production for ruminants and birds to promote growth and exert coccidiostat action. Despite the benefits of their use, poisonings have also been reported in several species. Equines are very sensitive, and most cases involve mistaken intake of feed intended for ruminants. This research described an outbreak of ionophore poisoning in seven horses and a mule that ingested livestock concentrate, confirmed by a chromatographic diagnostic method. A six-year-old horse was presented with clinical signs of sialorrhea, sweating, ataxia, prostration, anorexia, muscle tremors, lateral recumbency, posterior lateral decubitus, which began the day before. Laboratory tests showed increased AST (aspartate aminotransferase) and CK (creatine kinase) activities. Electrocardiogram revealed ventricular tachycardia. Due to the severity of the condition, the patient was euthanized on the day of admission, and a necropsy was performed, in which skeletal and cardiac muscle tissues were collected. Histology revealed multifocal necrosis in cardiomyocytes, necrosis, edema and hemorrhage in skeletal muscle. A visit was made to the property to evaluate other animals and collect samples for laboratory tests. All remaining animals underwent physical examination, two of which showed serious clinical signs. Three animals showed normocytic normochromic anemia, four increased creatinine, two had increased AST activity and all had increased CK activity. Among the poisoned animals, two died on the property. Liver sample from the first euthanized horse was examined by liquid chromatography coupled with mass spectrometry, identifying 51.59 µg/kg of monensin. It is concluded that, despite the recovery of the animals, the toxic action of the ionophore can cause injuries that affect equine health and welfare. The feasibility of chromatographic analysis is essential for a definitive diagnosis and must be subsequently developed together with reference values for tissue residues and maximum tolerated doses.